Browsing by Author "Oaknin Benzaquen, Ana Mazaltob"
Now showing items 1-20 of 33
-
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
Poveda, Andres; Oaknin Benzaquen, Ana Mazaltob; Romero, Ignacio; Guerrero‑Zotano, Angel; Fariñas Madrid, Lorena; Rodriguez‑Freixinos, Victor (Nature Research, 2021-02-24) -
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
Monk, Bradley J.; Parkinson, Christine; Lim, Myong Cheol; O’Malley, David M.; Oaknin Benzaquen, Ana Mazaltob; Wilson, Michelle (Lippincott Williams & Wilkins, 2022-12-01) -
Advances in immunotherapy for cervical cancer
Grau-Bejar, Juan Francisco; Garcia-Duran, Carmen; García Illescas, David; Mirallas Viñas, Oriol; Oaknin Benzaquen, Ana Mazaltob (SAGE Publications, 2023-03-28) -
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?
Lorusso, Domenica; Ray-Coquard, Isabelle; Oaknin Benzaquen, Ana Mazaltob; Banerjee, Susana (BMJ, 2020-10-13) -
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer
Oaknin Benzaquen, Ana Mazaltob; Monk, Bradley J.; de Melo, Andreia Cristina; Kim, Yong-Man; Lisyanskaya, Alla; Vergote, Ignace (Elsevier, 2022-10) -
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Garralda Cabanas, Elena; Aguilar, Susana; Sala De Vedruna, Gemma; Viaplana Donato, Cristina; González-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Mancuso, Francesco Mattia; Fasani, Roberta; Jiménez Flores, José Antonio; Martinez, Paola; Oaknin Benzaquen, Ana Mazaltob; Antunes de Melo Oliveira, Ana Mafalda; Balmaña Gelpí, Judith; Carles Galceran, Joan; Macarulla Mercadé, Teresa; Elez Fernandez, Mª Elena; Alsina Maqueda, Maria; Braña Garcia, Irene; Felip Font, Enriqueta; Tabernero Caturla, Josep; Rodon Ahnert, Jordi; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Ramos Masdeu, Laia; Saura Manich, Cristina; Ruiz Pace, Fiorella; Dienstmann, Rodrigo (American Society of Clinical Oncology, 2020-05-14) -
Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study
Tewari, Krishnansu S.; Sill, Michael W.; Birrer, Michael J.; Penson, Richard; Huang, Helen; Moore, David H.; Oaknin Benzaquen, Ana Mazaltob (Elsevier, 2023-04) -
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
Gonzalez-Martin, Antonio; Harter, Philipp; Lorusso, Domenica; Moore, Kathleen N; Oaknin Benzaquen, Ana Mazaltob; Banerjee, Susana (BMJ, 2020-12-11) -
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
Rodriguez Freixinos, Victor; Fariñas Madrid, Lorena; Garrido-Castro, Ana Christina; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Oaknin Benzaquen, Ana Mazaltob; Villacampa Javierre, Guillermo; Ruiz Pace, Fiorella; Dienstmann, Rodrigo (BMJ, 2019-03-08) -
ICO-ICS Praxi per al tractament mèdic del càncer epitelial d'ovari
Barretina-Ginesta, Maria-Pilar; Gil Martín, Marta; Guerra-Prió, Silvia; Lezcano-Rubio, Clara; Mangues-Bafalluy, Irene; Pardo, Beatriz; Piulats, Josep M.; Oaknin Benzaquen, Ana Mazaltob; Recalde-Penabad, Sabela; Romeo-Marín, Marga; Rey-Salido, Montserrat; Carreras Soler, Maria Josep (Institut Català de la SalutInstitut Català d'Oncologia, 2017-11) -
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
Garcia-Casado, Zaida; Oaknin Benzaquen, Ana Mazaltob; Mendiola, Marta; Alkorta-Aranburu, Gorka; Antunez-Lopez, Jose Ramon; Moreno-Bueno, Gema (MDPI, 2022-11-04) -
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Makker, Vicky; Taylor, Matthew H.; Aghajanian, Carol; Oaknin Benzaquen, Ana Mazaltob; Mier, James; Cohn, Allen L. (American Society of Clinical Oncology, 2020-09-10) -
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety
Oaknin Benzaquen, Ana Mazaltob; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Dean, Andrew; Colombo, Nicoletta (Wiley, 2021-10) -
Management of advanced ovarian cancer in Spain: an expert Delphi consensus
Redondo Sanchez, Andres; Oaknin Benzaquen, Ana Mazaltob; Rubio, Maria Jesus; Barretina-Ginesta, Maria-Pilar; de Juan Ferre, Ana; Manso, Luis (BMC, 2021-05-26) -
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
Swisher, Elizabeth M.; Kwan, Tanya T.; Oza, Amit M.; Tinker, Anna V.; Ray-Coquard, Isabelle; Oaknin Benzaquen, Ana Mazaltob (Nature Research, 2021-05-03) -
Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
Oaknin Benzaquen, Ana Mazaltob; Friedman, Claire F.; Roman, Lynda D.; D'Souza, Anishka; Braña Garcia, Irene; Bidard, François-Clement (Elsevier, 2020-10) -
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
Perez-Fidalgo, J. A.; Cortés, A.; Guerra, Eva; García, Y.; Iglesias, M.; Bohn Sarmiento, U.; Oaknin Benzaquen, Ana Mazaltob (Elsevier, 2021-08) -
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis
Poveda, Andres; Lheureux, S.; Cibula, David; Lindemann, Kristina; Weberpals, J.; Oaknin Benzaquen, Ana Mazaltob; Colombo, Nicoletta (Elsevier, 2022-03) -
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial
DiSilvestro, Paul; Kim, Byoung-Gie; Oaknin Benzaquen, Ana Mazaltob; Scambia, Giovanni; Banerjee, Susana; Colombo, Nicoletta (American Society of Clinical Oncology, 2023-01-20) -
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma
Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Oaknin Benzaquen, Ana Mazaltob; Dean, Andrew; Colombo, Nicoletta (American Society of Clinical Oncology, 2020-10-20)